Table 1 Demographic Characteristics
|  | Overall (n = 22) | Usual Care (n = 11) | Usual Care + Palliative Care (n = 11) |
|---|---|---|---|
Gender, n (%) | |||
 Male | 20 (90%) | 9 (82%) | 11 (100%) |
 Female | 2 (9%) | 2 (18%) | 0 (0%) |
Age, mean (SD) | 71.1 (7.6) | 69.5 (7.2) | 72.7 (8) |
Smoking Status, n (%) | |||
 Former | 21 (95%) | 11 (100%) | 10 (90%) |
 Never | 1 (5%) | 0 (0%) | 1 (9%) |
Family History of IPF, n (%) | |||
 No | 16 (73%) | 8 (72%) | 8 (73%) |
 Yes | 6 (27%) | 3 (27%) | 3 (27%) |
Comorbiditiesa, n (%) | |||
 No | 1 (5%) | 0 (0%) | 1 (9%) |
 Yes | 21 (95%) | 11 (100%) | 10 (90%) |
Duration of IPF, mean (SD) | 3.3 years (3) | 3.6 years (2.4) | 3.1 (3.6) |
Antifibrotic Treatment, n (%) | |||
 Pirfenidone | 10 (45%) | 6 (55%) | 4 (36%) |
 Nintedanib | 9 (41%) | 4 (36%) | 5 (45%) |
FVC, percent predicted, mean (SD) | 73.4% (18.8%) | 72.9% (18.7%) | 73.9% (19.8%) |
FVC, L, mean (SD) | 2.8 (0.7) | 2.8 (0.8) | 2.8 (0.6) |
DLCO, percent predicted, mean (SD) | 56.4% (13.8%) | 54.9% (14.2%) | 57.8% (13.9%) |
DLCO, L, mean (SD) | 14.1, (3.6) | 13.7 (3.7) | 14.5 (3.7) |
TLC, L, percent predicted | 68.9% (8.4%) | 65.4% (7.2%) | 71.4% (8.9%) |
TLC, L, mean (SD) | 4.8 (0.6) | 4.5 (0.7) | 5.1 (0.3) |
6 min walk distance (n = 9) | 540 m (SD 344.3) | 584 m (SD 447.4), n = 4 | 504.8 m (SD 289), n = 5 |